Binge eating disorder (BED) is included into eating disorders that are not otherwise specified in DSM-IV. It is similar to bulimia nervosa (BN) in that it has recurrent binge eating disorder episodes, and due to symptoms such as losing control during these episodes and due to symptoms such as losing control during these episodes. Some features such as eating faster than normal, eating without physical hunger and eating till feeling uncomfortable can be observed at least twice a week.


A 28 year old obese female patient was presented to psychiatry department upon the referral of obesity clinic. Her complaint was putting weight, cannot resist eating, unwillingness. In the performed tests pre-prandial blood sugar, thyroid hormone level and blood biochemistry were in normal borders. In addition, some indications such as episodes of recurrent binge eating disorders and uncontrollable eating during these episodes, willing to eat without having any sense of hunger and gaining weight.


The weight of obese patients with BED is related to overeating habits and their psychopathologies. The rate of depression was found to be higher in those with BED. The medicines used in the researches for the pharmacologic treatment of binge eating disorder are second generation antidepressants (selective serotonin reuptake inhibitors-SSRI), tricyclic antidepressants, anticonvulsants. Appetite suppressant features of anticonvulsants (Topiramate) are benefited and used for BED treatment.


Multidisciplinary approach is important in the treatment of obesity. Successful results have been obtained with psychiatric evaluation and with the treatment of psychopathologies.